These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27905557)

  • 1. Hallucinations in schizophrenia and Parkinson's disease: an analysis of sensory modalities involved and the repercussion on patients.
    Llorca PM; Pereira B; Jardri R; Chereau-Boudet I; Brousse G; Misdrahi D; Fénelon G; Tronche AM; Schwan R; Lançon C; Marques A; Ulla M; Derost P; Debilly B; Durif F; de Chazeron I
    Sci Rep; 2016 Dec; 6():38152. PubMed ID: 27905557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a Psycho-Sensory hAllucinations Scale (PSAS) in schizophrenia and Parkinson's disease.
    de Chazeron I; Pereira B; Chereau-Boudet I; Brousse G; Misdrahi D; Fénelon G; Tronche AM; Schwan R; Lançon C; Marques A; Debilly B; Durif F; Llorca PM
    Schizophr Res; 2015 Feb; 161(2-3):269-76. PubMed ID: 25481345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psycho-sensory modalities of visual hallucinations and illusions in Parkinson's disease.
    Marques A; Beze S; Lambert C; Bonamy L; de Chazeron I; Rieu I; Chiambaretta F; Durif F
    Rev Neurol (Paris); 2021 Dec; 177(10):1228-1236. PubMed ID: 34238577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olfactory and visual hallucinations in Parkinson's disease.
    Tousi B; Frankel M
    Parkinsonism Relat Disord; 2004 Jun; 10(4):253-4. PubMed ID: 15120101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual plus nonvisual hallucinations in Parkinson's disease: development and evolution over 10 years.
    Goetz CG; Stebbins GT; Ouyang B
    Mov Disord; 2011 Oct; 26(12):2196-200. PubMed ID: 21755536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of visual hallucinations across disorders.
    Dudley R; Aynsworth C; Mosimann U; Taylor JP; Smailes D; Collerton D; McCarthy-Jones S; Urwyler P
    Psychiatry Res; 2019 Feb; 272():86-92. PubMed ID: 30579187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What Is the Link Between Hallucinations, Dreams, and Hypnagogic-Hypnopompic Experiences?
    Waters F; Blom JD; Dang-Vu TT; Cheyne AJ; Alderson-Day B; Woodruff P; Collerton D
    Schizophr Bull; 2016 Sep; 42(5):1098-109. PubMed ID: 27358492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of hallucinations and delusions in Parkinson's disease.
    Holroyd S; Currie L; Wooten GF
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):734-8. PubMed ID: 11385005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and classification of hallucinations in multiple sensory modalities in schizophrenia spectrum disorders.
    Lim A; Hoek HW; Deen ML; Blom JD;
    Schizophr Res; 2016 Oct; 176(2-3):493-499. PubMed ID: 27349814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flickering Stimuli Do Not Reliably Induce Visual Hallucinations in Parkinson's Disease.
    Zarkali A; Lees AJ; Weil RS
    J Parkinsons Dis; 2019; 9(3):631-635. PubMed ID: 31227657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual hallucinations in Parkinson's disease: a review and phenomenological survey.
    Barnes J; David AS
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):727-33. PubMed ID: 11385004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hallucinations and conscious access to visual inputs in Parkinson's disease.
    Lefebvre S; Baille G; Jardri R; Plomhause L; Szaffarczyk S; Defebvre L; Thomas P; Delmaire C; Pins D; Dujardin K
    Sci Rep; 2016 Nov; 6():36284. PubMed ID: 27841268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing an aetiological model of visual hallucinations in Parkinson's disease.
    Gallagher DA; Parkkinen L; O'Sullivan SS; Spratt A; Shah A; Davey CC; Bremner FD; Revesz T; Williams DR; Lees AJ; Schrag A
    Brain; 2011 Nov; 134(Pt 11):3299-309. PubMed ID: 21921019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. I finally see what you see: Parkinson's disease visual hallucinations captured with functional neuroimaging.
    Goetz CG; Vaughan CL; Goldman JG; Stebbins GT
    Mov Disord; 2014 Jan; 29(1):115-7. PubMed ID: 23843193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reality monitoring and visual hallucinations in Parkinson's disease.
    Barnes J; Boubert L; Harris J; Lee A; David AS
    Neuropsychologia; 2003; 41(5):565-74. PubMed ID: 12559149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early- and late-latency gamma auditory steady-state response in schizophrenia during closed eyes: Does hallucination status matter?
    Griskova-Bulanova I; Hubl D; van Swam C; Dierks T; Koenig T
    Clin Neurophysiol; 2016 May; 127(5):2214-21. PubMed ID: 27072092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patients.
    Goetz CG; Wuu J; Curgian L; Leurgans S
    Mov Disord; 2006 Feb; 21(2):267-70. PubMed ID: 16161144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosis in Parkinson's disease: phenomenology, frequency, risk factors, and current understanding of pathophysiologic mechanisms.
    Fénelon G
    CNS Spectr; 2008 Mar; 13(3 Suppl 4):18-25. PubMed ID: 18323763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modality-general and modality-specific processes in hallucinations.
    Fernyhough C
    Psychol Med; 2019 Dec; 49(16):2639-2645. PubMed ID: 31530334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feeling of presence in Parkinson's disease.
    Fénelon G; Soulas T; Cleret de Langavant L; Trinkler I; Bachoud-Lévi AC
    J Neurol Neurosurg Psychiatry; 2011 Nov; 82(11):1219-24. PubMed ID: 21551471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.